Barreto EBL, Rattes IC, da Costa AV et al. Paneth cells and their multiple functions. Cell Biol Int. 2022;46:701–710.

Article  Google Scholar 

Tanaka M, Saito H, Kusumi T et al. Spatial distribution and histogenesis of colorectal Paneth cell metaplasia in idiopathic inflammatory bowel disease. J Gastroenterol Hepatol. 2001;16:1353–1359.

Article  CAS  PubMed  Google Scholar 

Kővári B, Báthori Á, Friedman MS et al. Histologic diagnosis of inflammatory bowel diseases. Adv Anat Pathol. 2022;29:48–61.

Article  PubMed  Google Scholar 

Wehkamp J, Harder J, Weichenthal M et al. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53:1658–1664.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Günther C, Martini E, Wittkopf N et al. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature. 2011;477:335–339.

Article  PubMed  PubMed Central  Google Scholar 

Frøslie KF, Jahnsen J, Moum BA et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133:412–422.

Article  PubMed  Google Scholar 

Reinisch W, Van Assche G, Befrits R et al. Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus. J Crohns Colitis. 2012;6:248–258.

Article  PubMed  Google Scholar 

Travis SP, Higgins PD, Orchard T, Panaccione R, Bitton A et al. Review article: defining remission in ulcerative colitis. Aliment Pharmacol Ther. 2011;34:113–124.

Article  CAS  PubMed  Google Scholar 

Reinink AR, Lee TC, Higgins PD. Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease: a meta-analysis. Inflamm Bowel Dis. 2016;22:1859–1869.

Article  PubMed  Google Scholar 

Bressler B, Marshall JK, Bernstein CN et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus. Gastroenterology. 2015;148:1035–58.e3.

Article  PubMed  Google Scholar 

Peyrin-Biroulet L, Bressenot A, Kampman W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin Gastroenterol Hepatol. 2014;12:929–34.e2.

Article  PubMed  Google Scholar 

Boal Carvalho P, Cotter J. Mucosal healing in ulcerative colitis: a comprehensive review. Drugs. 2017;77:159–173.

Article  CAS  PubMed  Google Scholar 

Dal Buono A, Roda G, Argollo M et al. Histological healing: should it be considered as a new outcome for ulcerative colitis? Expert Opin Biol Ther. 2020;20:407–412.

Article  Google Scholar 

Ma C, Sedano R, Almradi A et al. An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials. Gastroenterology. 2021;160:2291–2302.

Article  PubMed  Google Scholar 

Andreas S, Christian M, Emma C et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 2: IBD scores and general principles and technical aspects. J Crohns Colitis. 2019;13:273–284.

Article  Google Scholar 

Neeraj N, Achuthan A, Abdul-Aziz A et al. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission. Aliment Pharmacol Ther. 2020;52:1676–1682.

Article  Google Scholar 

Triana L, Talat B, Alexandra R et al. Prognostic value of histological activity in patients with ulcerative colitis in deep remission: a prospective multicenter study. United European Gastroenterol J. 2018;6:765–772.

Article  Google Scholar 

Park S, Abdi T, Gentry M et al. Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2016;111:1692–1701.

Article  PubMed  Google Scholar 

Narula N, Aruljothy A, Alshahrani AA et al. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission. Aliment Pharmacol Ther. 2020;52:1676–1682.

Article  CAS  PubMed  Google Scholar 

Nenci A, Becker C, Wullaert A et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557–561.

Article  CAS  PubMed  Google Scholar 

Ozaki R, Kobayashi T, Okabayashi S et al. Histological risk factors to predict clinical relapse in ulcerative colitis with endoscopically normal mucosa. J Crohns Colitis. 2018;12:1288–1294.

Article  PubMed  Google Scholar 

Roth S, Franken P, Sacchetti A et al. Paneth cells in intestinal homeostasis and tissue injury. PLoS One. 2012;7:e38965.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bitton A, Peppercorn MA, Antonioli DA et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120:13–20.

Article  CAS  PubMed  Google Scholar 

Bryant RV, Burger DC, Delo J et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut. 2016;65:408–414.

Article  CAS  PubMed  Google Scholar 

Simmonds N, Furman M, Karanika E et al. Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children. BMC Gastroenterol. 2014;14:93.

Article  PubMed  PubMed Central  Google Scholar 

Riley SA, Mani V, Goodman MJ et al. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991;32:174–178.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Magro F, Langner C, Driessen A et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7:827–851.

Article  CAS  PubMed  Google Scholar 

Barreiro-de Acosta M, Vallejo N, de la Iglesia D et al. Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs 1): a longitudinal cohort study. J Crohns Colitis. 2016;10:13–19.

Article  PubMed  Google Scholar 

Nakamura K, Sakuragi N, Takakuwa A et al. Paneth cell α-defensins and enteric microbiota in health and disease. Biosci Microbiota Food Health. 2016;35:57–67.

Article  CAS  PubMed  Google Scholar 

Sato T, van Es JH, Snippert HJ et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–418.

Article  CAS  PubMed  Google Scholar 

Jauregui-Amezaga A, López-Cerón M, Aceituno M et al. Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: a prospective study. Inflamm Bowel Dis. 2014;20:1187–1193.

Article  PubMed  Google Scholar 

Christensen B, Hanauer SB, Erlich J et al. Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes. Clin Gastroenterol Hepatol. 2017;15:1557–64.e1.

Article  PubMed  PubMed Central  Google Scholar 

Bessissow T, Lemmens B, Ferrante M et al. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am J Gastroenterol. 2012;107:1684–1692.

Article  PubMed  Google Scholar 

Tanaka M, Riddell RH, Saito H et al. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn’s disease from ulcerative colitis. Scand J Gastroenterol. 1999;34:55–67.

Article